SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



(Mark One)
x☒						QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED ~~SEPTEMBER 30, 2017~~MARCH 31, 2021
OR
¨☐						TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO

Commission file number: 001-37401

3326 Aspen Grove Drive

Franklin, Tennessee 37067

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x☒ No ¨☐

Indicate by check mark whether the registrant has submitted electronically ~~and posted on its corporate Web site, if any,~~ every Interactive Data File required to be submitted ~~and posted~~ pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit ~~and post~~ such files). Yes x☒ No ¨☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

~~smaller reporting company)~~

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act. x☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

The Registrant had ~~18,085,798~~24,417,124 shares of Common Stock, $0.01 par value per share, outstanding as of ~~October 31, 2017.~~April 30, 2021.

COMMUNITY HEALTHCARE TRUST INCORPORATED

~~September 30, 2017~~March 31, 2021

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands, except per share amounts)

Common stock, $0.01 par value; 450,000,000 shares authorized; 24,417,124 and 23,888,090 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively

(Unaudited)
September 30, 2017 December 31, 2016
ASSETS
Real estate properties
Land and land improvements $ 39,810
$ 29,884
Buildings, improvements, and lease intangibles 307,492
222,755
Personal property 112
97
Total real estate properties 347,414
252,736
Less accumulated depreciation (31,153 ) (18,404 )
Total real estate properties, net 316,261
234,332
Cash and cash equivalents 17,479
1,568
Mortgage note receivable, net 10,633
10,786
Other assets, net 10,776
4,843
Total assets $ 355,149
$ 251,529

LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Debt, net $ 59,284
$ 51,000
Accounts payable and accrued liabilities 3,226
3,541
Other liabilities 4,743
2,981
Total liabilities 67,253
57,522

Commitments and contingencies

Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding —
—
Common stock, $0.01 par value; 450,000,000 shares authorized; 18,085,798 and 12,988,482 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively 181
130
Additional paid-in capital 323,877
214,323
Cumulative net income 3,223
1,265
Accumulated other comprehensive loss (386 ) —
Cumulative dividends (38,999 ) (21,711 )
Total stockholders’ equity 287,896
194,007
Total liabilities and stockholders' equity $ 355,149
$ 251,529

See accompanying notes to the condensed consolidated financial statements.

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER 30, 2017~~MARCH 31, 2021 AND ~~2016~~2020

(Unaudited; Dollars in thousands, except per share amounts)

Three Months Ended September 30, Nine Months Ended
September 30,
2017 2016 2017 2016
REVENUES
Rental income $ 8,012
$ 4,985
$ 21,968
$ 13,188
Tenant reimbursements 1,158
1,188
3,620
3,250
Mortgage interest 255
270
774
1,367
Other operating 19
—
19
—
9,444
6,443
26,381
17,805

EXPENSES
Property operating 2,225
963
6,103
3,240
General and administrative 1,069
671
2,674
2,372
Depreciation and amortization 4,544
3,496
12,749
9,643
Bad debts —
73
67
103
7,838
5,203
21,593
15,358
OTHER INCOME (EXPENSE)
Interest expense (1,091 ) (185 ) (2,897 ) (787 )
Interest and other income, net 64
9
67
28
(1,027 ) (176 ) (2,830 ) (759 )
NET INCOME $ 579
$ 1,064
$ 1,958
$ 1,688

NET INCOME PER COMMON SHARE:
Net income per common share – Basic $ 0.02
$ 0.08
$ 0.10
$ 0.16
Net income per common share – Diluted $ 0.02
$ 0.08
$ 0.10
$ 0.16
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC 16,241,986
12,686,183
13,884,476
10,752,333
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED 16,241,986
12,750,967
13,884,476
10,802,095
DIVIDENDS DECLARED, PER COMMON SHARE, DURING THE PERIOD $ 0.3925
$ 0.3825
$ 1.1700
$ 1.1400

See accompanying notes to the condensed consolidated financial statements.

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER 30, 2017~~MARCH 31, 2021 AND ~~2016~~2020

(Unaudited; Dollars in thousands)


			Three Months Ended March 31,
			2021		2020

NET INCOME			$	5,315	$	4,100
	Other comprehensive income (loss):
		Increase (decrease) in fair value of cash flow hedges	2,803		(8,875)
		Reclassification for amounts recognized as interest expense	932		257
	Total other comprehensive income (loss)		3,735		(8,618)
COMPREHENSIVE INCOME (LOSS)			$	9,050	$	(4,518)

Three Months Ended September 30,
Nine Months Ended
September 30,
2017 2016 2017 2016

NET INCOME $ 579
$ 1,064
$ 1,958
$ 1,688
Other comprehensive income (loss):
Unrealized losses on cash flow hedges (74 ) —
(672 ) —
Reclassification of loss amounts recognized as interest expense 124
—
286
—
Total other comprehensive income (loss) 50
—
(386 ) —
COMPREHENSIVE INCOME $ 629
$ 1,064
$ 1,572
$ 1,688

See accompanying notes to the condensed consolidated financial statements.

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED ~~STATEMENT~~STATEMENTS OF STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED MARCH 31, 2021 AND 2020

(Unaudited; Dollars in thousands, except per share amounts)


	Preferred Stock			Common Stock			Additional Paid in Capital		Cumulative Net Income			Accumulated Other Comprehensive (Loss) Income		Cumulative Dividends		Total Stockholders' Equity
	Shares	Amount		Shares	Amount
Balance at December 31, 2020	0	$	0	23,888,090	$	239	$	550,391	$	36,631		$	(11,846)	$	(145,499)	$	429,916
Issuance of common stock, net of issuance costs	—	—		435,272	4		19,841		—			—		—		19,845
Stock-based compensation	—	—		93,762	1		1,549		—			—		—		1,550
Unrecognized gain on cash flow hedges	—	—		—	—		—		—			2,803		—		2,803
Reclassification adjustment for losses included in net income (interest expense)	—	—		—	—		—		—			932		—		932
Net income	—	—		—	—		—		5,315			—		—		5,315
Dividends to common stockholders ($0.4275 per share)	—	—		—	—		—		—			—		(10,275)		(10,275)
Balance at March 31, 2021	0	$	0	24,417,124	$	244	$	571,781	$	41,946		$	(8,111)	$	(155,774)	$	450,086

Balance at December 31, 2019	0	$	0	21,410,578	$	214	$	447,916	$	17,554		$	(4,808)	$	(107,465)	$	353,411
Issuance of common stock, net of issuance costs	—	—		610,786	6		26,896		—			—		—		26,902
Stock-based compensation	—	—		103,905	1		1,012		—			—		—		1,013
Unrecognized loss on cash flow hedges	—	—		—	—		—		—			(8,875)		—		(8,875)
Reclassification adjustment for losses included in net income (interest expense)	—	—		—	—		—		—			257		—		257
Net income	—	—		—	—		—		4,100			—		—		4,100
Dividends to common stockholders ($0.4175 per share)	—	—		—	—		—		—			—		(9,033)		(9,033)
Balance at March 31, 2020	0	$	0	22,125,269	$	221	$	475,824	$	21,654	0	$	(13,426)	$	(116,498)	$	367,775

Preferred Stock

Common Stock
Additional Paid in Capital Cumulative Net Income Accumulated Other Comprehensive Loss Cumulative Dividends Total Stockholders' Equity
Balance at December 31, 2016 $ —
$ 130
$ 214,323
$ 1,265
$ —
$ (21,711 ) $ 194,007
Issuance of common stock, net of issuance costs —
49
108,506
—
—
—
108,555
Stock-based compensation —
2
1,048
—
—
—
1,050
Unrecognized loss on cash flow hedges —
—
—
—
(672 ) —
(672 )
Reclassification adjustment for losses included in net income (interest expense) —
—
—
—
286
—
286
Net income —
—
—
1,958
—
—
1,958
Dividends to common stockholders ($1.17 per share) —
—
—
—
—
(17,288 ) (17,288 )
Balance at September 30, 2017 $ —
$ 181
$ 323,877
$ 3,223
$ (386 ) $ (38,999 ) $ 287,896

See accompanying notes to the condensed consolidated financial statements.

COMMUNITY HEALTHCARE TRUST INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; Dollars in thousands)

See accompanying notes to the condensed consolidated financial statements.

COMMUNITY HEALTHCARE TRUST INCORPORATED

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~September 30, 2017~~March 31, 2021

Note 1. Summary of Significant Accounting Policies

Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company conducts its business through an UPREIT structure in which its properties are owned by its operating partnership (the "OP"), either directly or through subsidiaries. The Company is the sole general partner of the OP, owning 100% of the OP units.providers. As of ~~September 30, 2017,~~March 31, 2021, the Company had investments of approximately ~~$358.0~~$801.0 million in 80147 real estate properties ~~including~~(including a ~~mortgage note,~~portion of 1 property accounted for as a financing lease with a gross amount totaling approximately $3.0 million and 1 property classified as held for sale with a gross amount totaling approximately $1.1 million). The properties are located in 2633 states, totaling approximately ~~1.8~~3.2 million square feet in the ~~aggregate.~~aggregate and were approximately 89.1% leased at March 31, 2021 with a weighted average remaining lease term of approximately 8.3 years. Any references to square footage, property count, or occupancy percentages, and any amounts derived from these values in these notes to the condensed consolidated financial statements, are outside the scope of our independent registered public accounting firm's review.

The world was, and continues to be, impacted by the novel coronavirus (COVID-19) pandemic. COVID-19 and measures to prevent its spread impacted many healthcare providers, including some of our tenants. During 2020, some of them were not seeing patients, others saw a reduced number of elective procedures and/or patient visits, while others experienced limited impact, or even saw improved cash flows from either increases in census or government funding.

As a result of the pandemic, the Company entered into deferral agreements with 18 tenants, with deferrals representing less than 1 percent of our annualized rent in the aggregate. Amounts due under the deferral agreements were generally repaid during 2020, however, at March 31, 2021, there was approximately $51,000 remaining to be billed and paid during the remainder of 2021.

Basis of Presentation

The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements.

This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2016.~~

2020. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, ~~2017.~~

~~Principles of Consolidation~~

Our Condensed Consolidated Financial Statements include the accounts of the Company, its wholly-owned subsidiaries, and may also include joint ventures, partnerships and variable interest entities, or VIEs, where the Company controls the operating activities.2021. All material intercompany accounts and transactions have been eliminated.

Management must make judgments regarding the Company's level of influence or control over an entity and whether or not the Company is the primary beneficiary of a VIE. Consideration of various factors include, but is not limited to, the Company's ability to direct the activities that most significantly impact the entity's governing body, the size and seniority of the Company's investment, and the Company's ability to replace the manager and/or liquidate the entity. Management's ability to correctly assess its influence or control over an entity when determining the primary beneficiary of a VIE affects the presentation of these entities in the Company's Condensed Consolidated Financial Statements. If it is determined that the Company is the primary beneficiary of a VIE, the Company's Condensed Consolidated Financial Statements would include the operating results of the VIE rather than the results of the variable interest in the VIE. Untimely or inaccurate financial information provided to the Company or deficiencies in the VIEs internal control over financial reporting could impact the Company's Condensed Consolidated Financial Statements and its own internal control over financial reporting.

During the third quarter of 2017, concurrent with the acquisition of a property, the Company entered into a $5.0 million note receivable with the tenant in the building. See Note 4. The Company identified the borrower as a VIE, but management determined that the Company was not the primary beneficiary of the VIE because we lack either directly or through related parties any material impact in the activities that impact its economic performance.

~~Notes to Condensed Consolidated Financial Statements - Continued~~

We are not obligated to provide support beyond our stated commitment to the borrower, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding note receivable as noted above.

~~Jumpstart Our Business Startups Act of 2012~~

The Company has elected the "emerging growth company" status as permitted under the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The Company elected to "opt out" of the provision allowed under the JOBS Act to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. As a result, we must comply with new or revised accounting standards as required when they are adopted. Our decision to opt out of the extended transition period under the JOBS Act is irrevocable.

Use of Estimates in the Condensed Consolidated Financial Statements

Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.

~~Segment Reporting~~

~~The Company acquires and owns healthcare-related real estate properties that are leased~~

Notes to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company is managed as one reporting unit, rather than multiple reporting units, for internal reporting purposes and for internal decision-making. Therefore, the Company discloses its operating results in a single segment.Condensed Consolidated Financial Statements - Continued

Cash, ~~and~~ Cash Equivalents and Restricted Cash

Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased.

~~Accounting for Real Estate Property Acquisitions~~

Real estate property acquisitions are accounted for as a business combination or an asset acquisition. An acquisition accounted for as a business combination is recorded at fair value and related closing costs are expensed. An acquisition accounted for as an asset acquisition is recorded at its purchase price, inclusive Restricted cash consists of ~~acquisition costs, which is allocated among~~amounts held by the ~~acquired assets and assumed liabilities based upon their relative fair values at the date~~lender of ~~acquisition. The Company adopted Accounting Standards Update ("ASU") No. 2017-01,~~ ~~Business Combinations (Topic 805): Clarifying the Definition of a Business, on January 1, 2017, and Company expects that substantially all of its acquisitions will be accounted for as asset acquisitions.~~

The allocation of real estate property acquisitions may include land and land improvements, building and building improvements, personal property, and identified intangible assets and liabilities (consisting of above- and below-market leases, in-place leases, and tenant relationships) based on the evaluation of information and estimates available at that date, and we allocate the purchase price based on these assessments. We make estimates of the acquisition date fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of pre-acquisition due diligence, tax records, and other sources. Based on these estimates, we recognize the acquired assets and liabilities at their estimated fair values. We expense transaction costs associated with business combinations in the period incurred. The fair value of tangible property assets acquired considers the value of the property as if vacant determined by comparable sales and other relevant data. The determination of fair value involves the use of significant judgment and estimation. We value land based on various inputs, which may include internal analysis of recently acquired properties, existing comparable properties within our portfolio, or third party appraisals or valuations based on comparable sales.

In recognizing identified intangible assets and liabilities of an acquired property, the value of above- or below-market leases is estimated based on the present value (using a discount rate which reflects the risks associated with the leases acquired) of the difference between contractual amounts to be received pursuant to the leases and management’s estimate of market lease rates measured over a period equal to the estimated remaining term of the

~~Notes to Condensed Consolidated Financial Statements - Continued~~

lease. In the case of a below-market lease, the Company would also evaluate any renewal options associated with that lease to determine if the intangible should include those periods. The capitalized above-market or below-market lease intangibles are amortized as a reduction from or an addition to rental income over the estimated remaining term of the respective leases.

In determining the value of in-place leases and tenant relationships, management considers current market conditions and costs to execute similar leases in arriving at an estimate of the carrying costs during the expected lease-up period from vacant to existing occupancy. In estimating carrying costs, management includes real estate taxes, insurance, other property operating expenses, estimates of lost rental revenue during the expected lease-up periods, and costs to execute similar leases, including leasing commissions. The values assigned to in-place leases and tenant relationships are amortized over the estimated remaining term of the lease. If a lease terminates prior to its scheduled expiration, all unamortized costs related to that lease are written off.

Depreciation and amortization of real estate assets and liabilities in place as of September 30, 2017, is recognized on a straight-line basis over the estimated useful life of the asset. The estimated useful lives at September 30, 2017 are as follows:



~~Land improvements~~	~~3 - 15 years~~
~~Buildings~~	~~20 - 40 years~~
~~Building improvements~~	~~3.0 - 39.8 years~~
~~Tenant improvements~~	~~2.3 - 6.9 years~~
~~Lease intangibles~~	~~1.4 - 13.7 years~~
~~Personal property~~	~~3 -10 years~~

~~Asset Impairments~~

The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever events occur or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant under-performance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its operators. In addition, the Company’s review for possible impairment may include those assets subject to purchase options and those impacted by casualties, such as tornadoes and hurricanes. If management determines that the carrying value of the Company’s assets may not be fully recoverable based on the existence of any of the factors above, or others, management would measure and record an impairment charge based on the estimated fair value of the property or the estimated fair value less costs to sell the property.

~~Fair Value Measurements~~

Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. In calculating fair value, a company must maximize the use of observable market inputs, minimize the use of unobservable market inputs and disclose in the form of an outlined hierarchy the details of such fair value measurements.

A hierarchy of valuation techniques is defined to determine whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:

~~Level 1~~ ~~– quoted prices for identical instruments in active markets;~~

~~Level 2~~ – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

~~Notes to Condensed Consolidated Financial Statements - Continued~~

~~Level 3~~ ~~– fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.~~

Our interest rate swaps are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as Level 2 in the hierarchy.

~~Lease Accounting~~

We, as a lessor, make a determination with respect to each of our leases whether they should be accounted for as operating leases or capital leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic useful life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. We believe all of our leases meet the accounting criteria to be accounted for as operating leases. Payments received under operating leases are accounted for in the Condensed Consolidated Statements of Income as rental revenue for actual cash rent collected plus or minus straight-line adjustments resulting from lease escalators. Assets subject to operating leases are reported as real estate investments in the Condensed Consolidated Balance Sheets.

Substantially all of our leases contain fixed or formula-based rent escalators. To the extent that the escalators are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.

~~Revenue Recognition~~

The Company recognizes rental revenue when it is realized or realizable and earned. There are four criteria that must be met before a company may recognize revenue, including persuasive evidence that an arrangement exists, delivery has occurred or services have been rendered (i.e., the tenant has taken possession of and controls the physical use of the leased asset), the price has been fixed or is determinable, and collectability is reasonably assured.

The Company derives most of its revenues from its real estate and mortgage note portfolio. The Company's rental and interest income is recognized based on contractual arrangements with its tenants and borrowers.

Rental income is recognized as earned over the life of the lease agreement on a straight-line basis. Recognizing rental revenue on a straight-line basis for leases may result in recognizing revenue in amounts more or less than amounts currently due from tenants. If management determines that the collectability of straight-line rents is not reasonably assured, the amount of future revenue recognized may be limited to amounts contractually owed and, where appropriate, establish an allowance for estimated losses. Straight-line rent included in rental income was approximately $0.4 million and $0.2 million, respectively, for the three months ended September 30, 2017 and 2016 and $1.0 million and $0.4 million, respectively, for the nine months ended September 30, 2017 and 2016.

~~Interest income is recognized based on the interest rates, maturity dates and amortization periods set forth within each note agreement. Fees received related to~~ our mortgage note ~~are amortized~~payable to ~~mortgage interest income on a straight-line basis which~~provide for future real estate tax, insurance expenditures and tenant improvements related to one property. The carrying amount approximates ~~amortization under the effective interest method.~~

Income received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities, was approximately $0.9 million and $0.8 million, respectively, at September 30, 2017 and December 31, 2016.

~~Allowance for Doubtful Accounts and Credit Losses~~

~~Accounts Receivable~~

Management monitors the aging and collectability of its accounts receivable balances on an ongoing basis. Whenever deterioration in the timeliness of payment from a tenant is noted, management investigates and determines the reason or reasons for the delay. Considering all information gathered, management’s judgment is exercised in determining whether a receivable is potentially uncollectible and, if so, how much or what percentage

~~Notes to Condensed Consolidated Financial Statements - Continued~~

may be uncollectible. Among the factors management considers in determining collectability are: the type of contractual arrangement under which the receivable was recorded (e.g., triple net lease, gross lease, or other type of agreement); the tenant’s reason for slow payment; industry influences under which the tenant operates; evidence of willingness and ability of the tenant to pay the receivable; credit-worthiness of the tenant; collateral, security deposit, letters of credit or other monies held as security; tenant’s historical payment pattern; other contractual agreements between the tenant and the Company; relationship between the tenant and the Company; the state in which the tenant operates; and the existence of a guarantor and the willingness and ability of the guarantor to pay the receivable. Considering these factors and others, management concludes whether all or some of the aged receivable balance is likely uncollectible. Upon determining that some portion of the receivable is likely uncollectible, the Company will record a provision for bad debts for the amount it expects will be uncollectible. When efforts to collect a receivable are exhausted, the receivable amount is charged off against the allowance. At September 30, 2017 and December 31, 2016, the Company had an allowance for bad debts of approximately $293,000 and $154,000, respectively.

~~Mortgage Note and Notes Receivable~~

~~The Company evaluates collectability of its notes receivable and records allowances as necessary. A note is impaired when it is probable that the Company will be unable to collect all amounts~~fair value due ~~according~~ to the ~~contractual terms~~short term maturity of ~~the loan as scheduled, including both contractual interest and principal payments. This assessment also includes an evaluation of the loan collateral. If~~these investments. The following table provides a mortgage loan becomes past due, the Company will review the specific circumstances and may discontinue the accrual of interest on the loan. The loan is not returned to accrual status until the debtor has demonstrated the ability to continue debt service in accordance with the contractual terms. Loans placed on non-accrual status will be accounted for on a cash basis, in which income is recognized only upon the receiptreconciliation of cash ~~or on a cost-recovery basis, in which all~~and cash ~~receipts reduce the carrying value of the loan, based on the Company's expectation of future collectability.~~equivalents and restricted cash:


	Balance as of March 31,
(Dollars in thousands)	2021		2020
Cash and cash equivalents	$	5,605	$	3,326
Restricted cash	398		282
Cash, cash equivalents and restricted cash	$	6,003	$	3,608

The Company had one mortgage note receivable outstanding as of September 30, 2017 and December 31, 2016 with a principal balance of $10.6 million and $10.9 million, respectively. Principal and interest are due monthly based on a 20-year amortization schedule, with a balloon payment due at maturity on September 30, 2026. At September 30, 2017 and December 31, 2016, approximately $336,000 and $87,000, respectively, in interest was due from the borrower and is included in other assets on our Condensed Consolidated Balance Sheets, of which approximately $253,000 and $0, respectively, was past due in accordance the terms of the underlying note.

The borrower and several related entities filed for voluntary bankruptcy on June 23, 2017. Upon filing for bankruptcy, the borrower was current on all obligations to the Company but no payments have been received during the bankruptcy. The Company has evaluated the collectability of the mortgage note which included an evaluation of the loan collateral, and based on information currently available, has determined that no impairment is required. As a result of the loan's past due status and the related circumstances surrounding the loan, the Company will continue to closely review the circumstances and reserve against accrued interest as needed based on events as they occur. The Company will continue to evaluate the collectability of the note as additional information becomes available.

The Company may receive loan or commitment fees upon the funding of a mortgage note. The Company will amortize those fees into income over the life of the mortgage note on a straight-line basis and will reflect the mortgage note, net of the unamortized fees, on its Consolidated Balance Sheet.

~~Stock-Based Compensation~~

The Company's 2014 Incentive Plan, as amended, (our "2014 Incentive Plan"), is intended to attract and retain qualified persons upon whom, in large measure, our sustained progress, growth and profitability depend, to motivate the participants to achieve long-term company goals and to more closely align the participants’ interests with those of our other stockholders by providing them with a proprietary interest in our growth and performance. The three distinct programs under the 2014 Incentive Plan are the ~~Amended and Restated Alignment of Interest Program, the~~ ~~Amended and Restated Executive Officer Incentive Program~~ ~~and the~~ ~~Non-Executive Officer Incentive Program~~. Our executive officers, officers, employees, consultants and non-employee directors are eligible to participate in the 2014 Incentive Plan. The 2014 Incentive Plan increases, on an annual basis, the number of shares of common stock available for issuance to an amount equal to 7% of the total number of shares of the Company’s common stock

~~Notes to Condensed Consolidated Financial Statements - Continued~~

outstanding on December 31 of the immediately preceding year. The 2014 Incentive Plan is administered by the Company’s compensation committee, which interprets the 2014 Incentive Plan and has broad discretion to select the eligible persons to whom awards will be granted, as well as the type, size and terms and conditions of each award, including the number of shares subject to awards and the expiration date of, and the vesting schedule or other restrictions (including, without limitation, restrictive covenants) applicable to, awards. The Company recognizes share-based payments to its directors and employees in its Condensed Consolidated Statements of Income on a straight-line basis over the requisite service period based on the fair value of the award on the measurement date.

~~Intangible Assets~~

Intangible assets with indefinite lives are not amortized, but are tested at least annually for impairment. Intangible assets with finite lives are amortized over their respective lives to their estimated residual values and are reviewed for impairment only when impairment indicators are present.

Identifiable intangible assets of the Company are generally comprised of in-place lease intangible assets, above- and below-market lease intangibles and deferred financing costs. In-place lease intangible assets are amortized on a straight-line basis over the applicable lives of the assets. Deferred financing costs are amortized to interest expense over the term of the related credit facility or other debt instrument using the straight-line method, which approximates the effective interest method.

~~Contingent Liabilities~~

From time to time, the Company may be subject to loss contingencies arising from legal proceedings and similar matters. Additionally, while the Company maintains comprehensive liability and property insurance with respect to each of its properties, the Company may be exposed to unforeseen losses related to uninsured or under-insured damages.

Management will monitor any matter that may present a contingent liability, and, on a quarterly basis, will review any reserves and accruals relating to the liabilities, adjusting provisions as necessary based on changes in available information. Liabilities for contingencies are first recorded when a loss is determined to be both probable and can be reasonably estimated. Changes in estimates regarding the exposure to a contingent loss will be reflected as adjustments to the related liability in the periods when they occur and will be disclosed in the notes to the Condensed Consolidated Financial Statements.

On occasion, the Company may also have acquisitions which include contingent consideration. In 2016, the Company acquired a medical office building and concurrently recorded the fair value of contingent purchase price of approximately $0.5 million. Subsequently, management monitored this contingency and adjusted its liability to its estimated fair value on a quarterly basis, offsetting property operating expense in the periods when they occurred. In April 2017, the Company paid approximately $0.4 million in settlement of this contingent liability.

Income Taxes

The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). WeThe Company and one subsidiary have also elected for ~~one of our subsidiaries~~that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company has ~~made provisions for federal and state~~recorded income ~~taxes~~tax expense or benefit for the ~~TRS.~~TRS to the extent applicable. The Company also evaluates the realizability of its deferred tax assets and will record valuation allowances if it is determined that more likely than not the asset will not be recovered. The Company intends at all times to qualify as a REIT under ~~Sections 856 and 860 of~~ the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a ~~real estate investment trust.~~REIT.

New Accounting Pronouncements

Reference Rate Reform

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848). ASU 2020-04 contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance in ASU 2020-04 is optional and may be elected over time as reference rate reform activities occur. During the first quarter of 2020, the Company elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company ~~classifies interest~~continues to evaluate the impact of the guidance and ~~penalties related to uncertain tax positions, if any,~~may apply other elections as applicable as additional changes in the ~~Condensed Consolidated Statements of Income as a component of general and administrative expenses.~~market occur.

~~Sales and Use Taxes~~

Notes to Condensed Consolidated Financial Statements - Continued

The Company must pay sales and use taxes to certain state tax authorities based on rent collected from tenants in properties located in those states. The Company is generally reimbursed for those taxes by those tenants. The Company accounts for the payments to the taxing authority and subsequent reimbursement from the tenant on a net basis, included in tenant reimbursement revenue on the Company’s Condensed Consolidated Statements of Income.

~~Concentration of Credit Risks~~

Our credit risks primarily relate to cash and cash equivalents, our mortgage note receivable and our interest rate swaps, which are discussed below. Cash and cash equivalents are primarily held in bank accounts and overnight investments. We maintain our bank deposit accounts with large financial institutions in amounts that often exceed federally-insured limits. We have not experienced any losses in such accounts.

~~Derivative Financial Instruments~~

In the normal course of business, we are subject to risk from adverse fluctuations in interest rates. We have chosen to manage this risk through the use of derivative financial instruments, or interest rate swaps. Counterparties to these contracts are major financial institutions. We are exposed to credit loss in the event of nonperformance by these counterparties. We do not use derivative instruments for trading or speculative purposes. Our objective in managing exposure to market risk is to limit the impact on cash flows. To qualify for hedge accounting, our interest rate swaps must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions must be, and be expected to remain, probable of occurring in accordance with our related assertions. All of our hedges are cash flow hedges and are recognized at their fair value in the Condensed Consolidated Balance Sheets. Changes in the fair value of the derivatives are recognized in accumulated other comprehensive loss.

~~Earnings per Share~~

Basic earnings per common share is calculated using weighted average shares outstanding less issued and outstanding non-vested shares of common stock. Diluted earnings per common share is calculated using weighted average shares outstanding plus the dilutive effect of the non-vested shares of common stock using the treasury stock method and the average stock price during the period.

~~New Accounting Pronouncements~~

~~On July 1, 2017, the Company adopted the Financial Accounting Standard Board's ("FASB") ASU No. 2017-12,~~ ~~Derivatives and Hedging Topic 815: Targeted Improvements to Accounting for Hedging Activities,~~ ("ASU 2017-12"). ASU 2017-12 is intended to better align an entity’s financial reporting for hedging activities with the economic objectives of those activities. Upon adoption of ASU 2017-12, the cumulative ineffectiveness that a company had previously recognized on existing cash flow and net investment hedges is adjusted and removed from beginning retained earnings and placed in accumulated other comprehensive income. The adoption of ASU 2017-12 did not have an impact on our financial statements as we had not previously recognized any hedge ineffectiveness related to our existing cash flow hedges. In future periods, for hedges that are deemed highly effective, we will no longer need to recognize any hedge ineffectiveness, and all gains or losses will be recognized in other comprehensive income.

~~In February 2016, the FASB issued ASU No. 2016-02,~~ ~~Leases~~ (“ASU 2016-02”). This standard requires a lessor to classify leases as either sales-type, finance or operating. A lease will be treated as a sale if it transfers all of the risks and rewards, as well as control of the underlying asset, to the lessee. If risks and rewards are conveyed without the transfer of control, the lease is treated as a financing. If the lessor doesn’t convey risks and rewards or control, an operating lease results. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessors for sales-type, direct financing, and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. Lease components will continue to be recognized on a straight-line basis over the lease term and certain non-lease components will be accounted for under the new revenue recognition guidance in the Revenue ASUs. The Company is still evaluating the complete impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position, results of operations and disclosures.

~~Notes to Condensed Consolidated Financial Statements - Continued~~

~~Between May 2014 and May 2016, the FASB issued three ASUs changing the requirements for recognizing and reporting revenue (together, herein referred to as the “Revenue ASUs”): (i) ASU No. 2014-09,~~ ~~Revenue from Contracts with Customers~~ ~~(“ASU 2014-09”), (ii) ASU No. 2016-08,~~ ~~Principal versus Agent Considerations (Reporting Revenue Gross versus Net)~~ ~~(“ASU 2016-08”) and (iii) ASU No. 2016-12,~~ ~~Narrow-Scope Improvements and Practical Expedients~~ (“ASU 2016-12”). ASU 2014-09 provides guidance for revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2016-08 is intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. ASU 2016-12 provides practical expedients and improvements on the previously narrow scope of ASU 2014-09. In August 2015, the FASB issued ASU No. 2015-14, ~~Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date~~ (“ASU 2015-14”). ASU 2015-14 defers the effective date of ASU 2014-09 by one year to fiscal years, and interim periods within, beginning after December 15, 2017. The Company intends on adopting the Revenue ASUs on January 1, 2018. A reporting entity may apply the amendments in the Revenue ASUs using either a modified retrospective approach, by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption or full retrospective approach.

The primary source of revenue for the Company is generated through leasing arrangements, which are excluded from the Revenue ASUs. However, we expect that the recognition of non-lease revenue will be impacted due to the principle versus agent considerations in the Revenue ASUs that will become effective upon the adoption of ASU 2016-02 on January 1, 2019. Also, under ASU 2014-09, revenue recognition for real estate sales is largely based on the transfer of control versus continuing involvement under current guidance. The Company has not yet elected a transition method and is evaluating the complete impact of the adoption of the Revenue ASUs on January 1, 2018 to its consolidated financial position, results of operations and disclosures. The Company expects to complete its overall evaluation of the impact of the Revenue ASUs during the fourth quarter of 2017, with continued evaluations during 2018 of the impact to its non-lease revenue upon adoption of ASU 2016-02 in 2019.

~~In June 2016, the FASB issued ASU No. 2016-13,~~ ~~Financial Instruments-Credit Losses,~~ ("ASU 2016-13"), which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies will be required to use a new forward-looking “expected loss” model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies will measure credit losses in a manner similar to what they do today, except that the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. Companies will have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies will apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This standard is effective for the Company on January 1, 2020 with early adoption permitted. The Company is in the initial stage of evaluating the impact of this new standard on its notes and trade receivables.

~~In August 2016, the FASB issued ASU No. 2016-15,~~ ~~Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments,~~ ~~("ASU 2016-15")~~, which clarifies or provides guidance relating to eight specific cash flow classification issues. The standard should be applied retrospectively for each period presented, as appropriate. This new standard is effective for the Company on January 1, 2018 with early adoption permitted. Of the eight areas addressed, the Company expects that its presentation on its statements of cash flows could be impacted relating to cash payments of contingent consideration or settlement of insurance claims, based on historical transactions. In the future, however, the impact of this new guidance will depend on future transactions, though the impact will only be related to the classification of those items on the statement of cash flows and will not impact the Company's cash flows or its results of operations.

~~In May 2017, the FASB issued ASU No. 2017-09,~~ ~~Compensation - Stock Compensation (Topic 718)~~, ("ASU 2017-09"), which provides guidance about which changes in the terms or conditions of a share-based payment award require a company to apply modification accounting in Topic 718. Under ASU No. 2017-09, a company will generally be required to apply modification accounting unless the fair value or intrinsic value of the modified award, the vesting conditions of the modified award, and the classification of the modified award as equity or a liability are

~~Notes to Condensed Consolidated Financial Statements - Continued~~

the same as the original award immediately before the award is modified. This standard is effective for the Company on January 1, 2018 with early adoption permitted. The Company does not believe the adoption of this standard will have an impact on its results of operations, but could impact the accounting on future modifications of share-based awards.

Note 2. Real Estate ~~Investments~~Properties

~~At September 30, 2017, the Company~~As of March 31, 2021, we had investments of approximately ~~$358.0~~$801.0 million in 80147 real estate properties ~~including~~(including a ~~mortgage note.~~portion of 1 property accounted for as a financing lease with a gross amount totaling approximately $3.0 million and 1 property classified as held for sale with a gross amount totaling approximately $1.1 million). The Company's investments are diversified by property type, geographic location, and tenant as shown in the following ~~table summarizes the Company's real estate investments.~~tables:


Property Type	# of Properties	Gross Investment (in thousands)
Medical Office Building	55	$	256,204
Acute Inpatient Behavioral	5	130,257
Inpatient Rehabilitation Facilities	6	127,676
Specialty Centers	34	106,054
Physician Clinics	28	80,886
Surgical Centers and Hospitals	10	54,071
Behavioral Specialty Facilities	8	30,945
Long-term Acute Care Hospitals	1	14,937
Total	147	$	801,030


State	# of Properties	Gross Investment (in thousands)
Texas	14	$	131,131
Illinois	16	119,233
Florida	14	65,649
Ohio	18	63,188
Massachusetts	2	35,298
All Others (Less than 4%)	83	386,531
Total	147	$	801,030


Primary Tenant	# of Properties	Gross Investment (in thousands)
US Healthvest	3	$	77,964
Everest Rehabilitation	3	57,100
Genesis Care	9	38,450
Summit Behavioral Healthcare	1	25,155
All Others	131	602,361
Total	147	$	801,030

(Dollars in thousands)
Number of Facilities
Land and
Land Improvements
Buildings, Improvements, and Lease Intangibles

Personal
Property

Total

Accumulated Depreciation
Medical office buildings:
Florida 4
$ 4,138
$ 23,777
$ —
$ 27,915
$ 2,168
Ohio 5
3,167
23,518
—
26,685
2,912
Texas 3
3,096
12,315
—
15,411
2,950
Kansas 2
1,427
10,497
—
11,924
2,317
Iowa 1
2,241
8,979
—
11,220
885
Illinois 2
1,134
11,791
—
12,925
1,374
Virginia 1
369
4,649
—
5,018
156
Other states 13
3,273
22,695
—
25,968
1,970
31
18,845
118,221
—
137,066
14,732
Physician clinics:
Kansas 3
1,638
10,899
—
12,537
1,780
Florida 3
—
5,950
—
5,950
462
Illinois 1
1,891
3,134
—
5,025
31
Other states 9
3,195
18,461
—
21,656
2,719
16
6,724
38,444
—
45,168
4,992
Surgical centers and hospitals:
Louisiana 1
1,683
21,353
—
23,036
444
Indiana 1
523
14,405
—
14,928
188
Michigan 2
628
8,272
—
8,900
1,713
Illinois 1
2,183
5,410
—
7,593
634
Florida 1
271
7,004
—
7,275
118
Arizona 2
576
5,389
—
5,965
874
Other states 5
1,555
11,001
—
12,556
2,675
13
7,419
72,834
—
80,253
6,646
Specialty centers:
Alabama 3
415
4,417
—
4,832
1,170
Nevada 1
276
4,402
—
4,678
183
Kentucky 1
193
3,432
—
3,625
732
Other states 10
1,716
15,227
—
16,943
1,786
15
2,600
27,478
—
30,078
3,871
Behavioral facilities:
West Virginia 1
2,138
22,897
—
25,035
7
Illinois 1
1,300
18,803
—
20,103
627
Ohio 1
514
4,153
—
4,667
52
Indiana 1
270
2,651
—
2,921
127
4
4,222
48,504
—
52,726
813
Corporate property —
—
2,011
112
2,123
99
Total owned properties 79
$ 39,810
$ 307,492
$ 112
$ 347,414
$ 31,153
Mortgage note receivable, net 1
—
—
—
10,633
—
Total real estate investments 80
$ 39,810
$ 307,492
$ 112
$ 358,047
$ 31,153

~~Notes to Condensed Consolidated Financial Statements - Continued~~

Note 3. Real Estate Leases

The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through ~~2033.~~2039. The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and may also include additional rent, which may include the reimbursement of taxes (including property ~~tax)~~taxes), insurance, maintenance and other operating costs associated with the leased property.

Notes to Condensed Consolidated Financial Statements - Continued

Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. Some leases also allow the lessee to renew or extend their lease term or in some cases terminate their lease, based on conditions provided in the lease.

Future minimum lease payments under the non-cancelable operating leases due to the Company for the years ending December 31, as of ~~September 30, 2017,~~March 31, 2021, are as follows (in thousands):

2017 $ 8,292
2018 30,409
2019 27,202
2020 24,497
2021 21,541
2022 and thereafter 134,018
$ 245,959

Straight-line rental income

Rental income is recognized as earned over the life of the lease agreement on a straight-line basis when collection of rental payments over the term of the lease is probable. Straight-line rent included in rental income was approximately $0.8 million and $0.9 million, respectively, for the three months ended March 31, 2021 and 2020.

Note 4. Real Estate Acquisitions and Dispositions

~~Property~~2021 Real Estate Acquisitions

During the ~~third~~first quarter of ~~2017,~~2021, the Company acquired ~~two~~6 real estate ~~properties totaling approximately~~ ~~147,000~~ ~~square feet for an aggregate purchase price and cash consideration of approximately~~ ~~$28.3 million. Upon acquisition, the properties were~~ ~~100%~~ ~~leased in the aggregate with lease expirations ranging from 2022 through 2032. In addition, we funded a $5.0 million mezzanine loan to the tenant of one of the~~ properties. Amounts reflected in revenues and net income for the three months ended September 30, 2017 for these properties was approximately $44,000 and $31,000, respectively. Transaction costs totaling approximately $65,000 related to these acquisitions were capitalized in the period as part of the real estate assets and approximately $11,000 was expensed related to the mezzanine loan.

During the second quarter of 2017, the Company acquired 10 real estate properties totaling approximately 203,000 square feet for an aggregate purchase price of approximately $36.2 million, including cash consideration of approximately $35.9 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ~~ranging from 2019~~ through ~~2032.~~2036. Amounts reflected in revenues and net income for these properties for the ~~nine~~three months ended ~~September 30, 2017 for these properties was~~March 31, 2021 were approximately ~~$1.3~~$0.7 million and ~~$0.6~~$0.4 million, ~~respectively. Transaction~~respectively, and transaction costs totaling approximately ~~$0.3~~$0.2 million ~~related~~were capitalized relating to these ~~acquisitions were capitalized in~~property acquisitions. Concurrent with the ~~period as part of the real estate assets.~~

~~During the first quarter of 2017,~~acquisitions, the Company ~~acquired 10 real estate properties totaling approximately 145,000 square feet for an aggregate purchase price~~entered into a $6.0 million term loan and a revolver loan up to $4.0 million with the tenant on two of approximately $28.5 million, including cash consideration of approximately $28.4 million. Upon acquisition, the properties were 95.2% leased in the aggregate with lease expirations ranging from 2018 through 2032. Amounts reflected in revenues and net income for the nine months ended September 30, 2017 for these properties was approximately $1.9 million and $0.5 million, respectively. Transaction costs totaling approximately $0.4 million related to these acquisitions were capitalized in the period as part of the real estate assets. During the first quarter of 2017, the Company also acquired a property, adjacent to its corporate office, for a cash purchase price of approximately $0.9 million. The property is currently leased to a tenant but the Company intends to use the property for future expansion of its corporate office.properties.


Location	Property Type (1)	Date Acquired	Purchase Price		Cash Consideration		Real Estate		Other		Square Footage
			(000's)		(000's)		(000's)		(000's)
Brenham, TX	PC	01/19/21	$	5,029	$	5,034	$	5,072	$	(38)	37,354
Lexington, VA	PC	01/25/21	3,101		3,142		3,151		(9)		15,820
Toledo, OH	BSF	02/05/21	4,825		4,893		4,893		0		13,290
Hudson, OH	BSF	02/05/21	4,825		4,892		4,892		0		13,290
Oklahoma City, OK	IRF	03/01/21	21,000		21,025		21,025		0		39,637
Keller, TX	IRF	03/01/21	21,000		21,021		21,021		0		39,761
			$	59,780	$	60,007	$	60,054	$	(47)	159,152

(1) PC - Physician Clinic; BSF - Behavioral Specialty Facility; IRF - Inpatient Rehabilitation Facility

Notes to Condensed Consolidated Financial Statements - Continued

The following table summarizes the ~~estimated~~relative fair values of the assets acquired and liabilities assumed in the property acquisitions for the ~~nine~~three months ended ~~September 30, 2017.~~

March 31, 2021.

Estimated Fair Value Estimated Useful Life
(In thousands) (In years)
Land and land improvements $ 9,715
5 - 7.5
Building and building improvements 74,891
20 - 40
Intangibles:
In place lease intangibles 9,527
1.4 - 8.9
Total intangibles 9,527

Accounts receivable and other assets assumed 32

Accounts payable, accrued liabilities and other liabilities assumed ⁽¹⁾
(416 )
Prorated rent, interest and operating expense reimbursement amounts collected (307 )
Total cash consideration $ 93,442

⁽¹⁾ Includes security deposits received.


			Relative Fair Value		Estimated Useful Life
			(in thousands)		(in years)
Land and land improvements			$	7,813	13.2
Building and building improvements			49,630		46.4
Intangibles:
	At-market lease intangibles		2,611		4.2


		Total intangibles	2,611

Accounts payable, accrued liabilities and other liabilities assumed			(12)
Prorated rent, interest and operating expense reimbursement amounts collected			(35)
	Total cash consideration		$	60,007

Pursuant to the exercise of a purchase option by a tenant, the Company entered into a sales contract to dispose of a medical office building in Haleyville, Alabama during the first quarter of 2021. Assets held for sale totaling approximately $1.0 million are included in Other assets, net and Liabilities held for sale totaling $35,000 are included in Other liabilities, net on the Condensed Consolidated Balance Sheet as of March 31, 2021.

The table below details the Company's debt as of ~~September 30, 2017~~March 31, 2021 and December 31, ~~2016.~~2020.


	Balance as of
(Dollars in thousands)	March 31, 2021		December 31, 2020		Maturity Dates

Revolving Credit Facility	$	7,000	$	33,000	3/26
A-1 Term Loan, net	0		49,908		n/a
A-2 Term Loan, net	49,749		49,828		3/24
A-3 Term Loan, net	74,396		74,524		3/26
A-4 Term Loan, net	124,211		0		3/28
Mortgage Note Payable, net	5,090		5,114		5/24
	$	260,446	$	212,374

Balance as of
(Dollars in thousands)
September 30,
2017
December 31, 2016 Maturity Dates

Revolving Credit Facility $ —
$ 51,000
8/19
5-Year Term Loan, net 29,648
—
3/22
7-Year Term Loan, net 29,636
—
3/24
$ 59,284
$ 51,000

On March ~~29, 2017, we~~19, 2021, Community Healthcare Trust Incorporated, as borrower, entered into a ~~second~~third amended and restated credit agreement (the “Third Amended and Restated Credit ~~Facility (as amended~~Agreement”) with a syndicate of lenders, under which Truist Bank serves as administrative agent. The Third Amended and ~~restated,~~Restated Credit Agreement amends and restates the ~~"Credit Facility"). The~~Second Amended and Restated Credit ~~Facility is~~Agreement dated as of March 29, 2017, by and among the Company’s operating partnership, Community Healthcare OP, LP, ~~the Company, the Lenders from time to time~~several banks and financial institutions party thereto as lenders (collectively, the “Lenders”), and SunTrust Bank (the predecessor in interest to Truist Bank), as ~~Administrative Agent.~~the administrative agent. The ~~Company’s material subsidiaries are guarantors of~~Third Amended and Restated Credit Agreement allows the ~~obligations under~~Company to borrow, through the accordion feature, up to $600.0 million, including the ability to add and fund incremental term loans (the “Credit Facility”). The Third Amended and Restated Credit ~~Facility. The Credit Facility provides for a $150.0 million~~Agreement extended the revolving credit facility (the "Revolving Credit Facility") maturity to March 19, 2026, removed collateral security provisions, repaid the five-year term loan facility in the aggregate principal amount of $50.0 million (the "A-1 Term Loan") which was set to mature

Notes to Condensed Consolidated Financial Statements - Continued

on March 29, 2022, entered into a new seven-year term loan facility in the aggregate principal amount of $125.0 million (the "A-4 Term Loan"), which matures on March 19, 2028, provides the Company the ability to apply lower margins to its annual interest rate after it obtains an investment grade rating of BBB-/Baa3 (or the equivalent) from a rating agency; and ~~$100.0~~modified its debt covenants.

The Credit Facility, as amended, provides for a $150.0 million Revolving Credit Facility and $250.0 million in term loans (the "Term Loans"). The Credit Facility, through the accordion feature, allows borrowings up to a total of ~~$450.0~~$600.0 million including the ability to add and fund additional term loans. The Revolving Credit Facility matures on ~~August 9, 2019~~March 19, 2026 and includes ~~two~~1 12-month ~~options~~option to extend the maturity date of the Revolving Credit Facility, subject to the satisfaction of certain conditions. The Term Loans include a ~~five-year term loan facility in the aggregate principal amount of $50.0 million (the "5-Year Term Loan") which matures on March 29, 2022 and a~~ seven-year term loan facility in the aggregate principal amount of $50.0 million (the ~~"7-Year~~"A-2 Term Loan"), which matures on March 29, ~~2024. Upon closing~~2024, a seven-year term loan facility in the aggregate principal amount of ~~the Credit Facility~~$75.0 million (the "A-3 Term Loan"), which matures on March 29, ~~2017,~~2026, and the ~~Company borrowed $30.0 million under each of the 5-Year~~A-4 Term Loan ~~and~~in the ~~7-Year Term Loan. Each~~aggregate principal amount of ~~the 5-Year Term Loan and 7-Year Term Loan has a delayed draw feature that is available in up to three draws within 15 months from~~$125.0 million, which matures on March 29, 2017, subject to a minimum draw of $10.0 million and pro forma compliance. The Company incurred approximately $784,000 in fees and other costs upon closing of the Credit Facility which are netted against the term loans and are being amortized to interest expense on a straight-line basis which approximates the effective interest method.19, 2028.

~~Notes to Condensed Consolidated Financial Statements - Continued~~

Amounts outstanding under the Revolving Credit Facility, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus ~~1.75%~~1.25% to ~~2.75%~~1.90% or (ii) a base rate plus ~~0.75%~~0.25% to ~~1.75%,~~0.90% in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to ~~0.25%~~0.20% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and ~~0.35%~~0.25% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity under the Revolving Credit Facility. ~~At September 30, 2017, the~~The Company had ~~no balance~~$7.0 million outstanding under the Revolving Credit Facility ~~with~~and had a ~~remaining~~ borrowing capacity remaining of ~~$150.0 million.~~$143.0 million at March 31, 2021.

Amounts outstanding under the Term Loans, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus ~~2.2%~~1.45% to ~~2.9%~~2.30% or (ii) a base rate plus ~~1.25%~~0.25% to ~~1.9%~~1.30%, in each case, depending upon the Company’s leverage ratio. ~~In addition, the~~The Company ~~is obligated to pay an annual fee equal to 0.35% of the amount of the unused portion of the Term Loans. The Company~~has entered into interest rate swaps to fix the interest rates on the ~~term loans as discussed in~~Term Loans. See Note 6.6 for more details on the interest rate swaps. At ~~September 30, 2017,~~March 31, 2021, the Company had ~~$60.0~~$250.0 million ~~outstanding~~ under the Term Loans ~~with~~which had a fixed weighted average interest rate under the swaps of ~~approximately 4.34% and remaining borrowing capacity of $40.0 million.~~approximately 3.95%.

The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. ~~Also, the Company’s present financing policy prohibits incurring debt (secured or unsecured) in excess of 40% of its total book capitalization.~~ The Company was in compliance with its financial covenants under its Credit Facility ~~at September 30, 2017.~~as of March 31, 2021.

Note 6. Derivative Financial Instruments

Risk Management Objective of Using Derivatives

The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations.

Notes to Condensed Consolidated Financial Statements - Continued

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish ~~this objective,~~these objectives, the Company primarily uses interest rate swaps ~~and/or caps~~ as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. ~~Interest rate caps designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract.~~

As of ~~September 30, 2017,~~March 31, 2021, the Company had ~~two~~14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling ~~$60.0 million.~~ $250.0 million, including 4 forward-starting interest rate swaps for notional amounts totaling $50.0 million, which will not become effective until March 31, 2022.

Tabular Disclosure of Fair Value of Derivative Instruments on the Balance Sheet

The ~~Company had recorded~~table below presents the fair value of ~~its interest rate derivatives totaling approximately $386,000 in other liabilities in its~~the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance ~~Sheet.~~Sheets as of March 31, 2021 and December 31, 2020.


	Asset Derivatives Fair Value at					Liability Derivatives Fair Value at
(Dollars in thousands)	March 31, 2021		December 31, 2020		Balance Sheet Classification	March 31, 2021		December 31, 2020		Balance Sheet Classification
Interest rate swaps	$	538	$	0	Other assets, net	$	8,649	$	11,846	Other liabilities, net

~~Notes to Condensed Consolidated Financial Statements - Continued~~

The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive loss ("AOCI") and isare subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings.

Amounts reported in ~~accumulated other comprehensive loss~~AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional ~~$0.3~~$4.5 million will be reclassified from ~~other comprehensive income ("OCI")~~AOCI as an increase to interest expense.

Tabular Disclosure of the Effect of Fair Value and Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)

The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three ~~and nine~~ months ended ~~September 30, 2017.~~March 31, 2021 and 2020.


	Three Months Ended March 31,
(Dollars in thousands)	2021		2020
Amount of unrealized gain (loss) recognized in OCI on derivatives	$	2,803	$	(8,875)
Amount of loss reclassified from AOCI into interest expense	$	932	$	257
Total interest expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$	2,229	$	2,249

Tabular Disclosures of Offsetting Derivatives

The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company's derivatives as of March 31, 2021 and December 31, 2020. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented on the Condensed Consolidated Balance Sheets.

Notes to Condensed Consolidated Financial Statements - Continued

(Dollars in thousands) Three Months Ended
September 30, 2017 Nine Months Ended
September 30, 2017
Amount of gain (loss) recognized in OCI on derivative $ (74 ) $ (672 )
Amount of gain (loss) reclassified from accumulated OCI into interest expense $ (124 ) $ (286 )
Total Interest (Expense) presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded $ 1,091
$ 2,897


Offsetting of Derivative Assets (as of March 31, 2021)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(in thousands)	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Assets in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	538	$	0	$	538	$	(278)	$	0	$	260


Offsetting of Derivative Liabilities (as of March 31, 2021)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(in thousands)	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Liabilities in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	(8,649)	$	0	$	(8,649)	$	278	$	0	$	(8,371)


Offsetting of Derivative Assets (as of December 31, 2020)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(in thousands)	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Assets in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	0	$	0	$	0	$	0	$	0	$	0


Offsetting of Derivative Liabilities (as of December 31, 2020)
							Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
(in thousands)	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Condensed Consolidated Balance Sheet		Net Amounts of Liabilities in the Condensed Consolidated Balance Sheets		Financial Instruments		Cash Collateral Received		Net Amount
Derivatives	$	(11,846)	$	0	$	(11,846)	$	0	$	0	$	(11,846)

Credit-risk-related Contingent Features

As of ~~September 30, 2017,~~March 31, 2021, the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was ~~$0.4~~$8.6 million. As of ~~September 30, 2017,~~March 31, 2021, the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value of approximately ~~$0.4~~$8.6 million at ~~September 30, 2017.~~March 31, 2021.

Notes to Condensed Consolidated Financial Statements - Continued

Note 7. Stockholders’ Equity

The following table provides a reconciliation of the beginning and ending common stock balances for the ~~nine~~three months ended ~~September 30, 2017~~March 31, 2021 and for the year ended December 31, ~~2016:~~2020:

~~On July 26, 2017,~~The Company has an at-the-market offering program ("ATM Program"), with Piper Sandler & Co., Evercore Group L.L.C., Truist Securities, Inc., Regions Securities LLC, Robert W. Baird & Co. Incorporated, Fifth Third Securities, Inc. and Janney Montgomery Scott LLC., as sales agents (collectively, the “Agents”). Under the ATM Program, the Company ~~completed a public offering of 4,887,500~~may issue and sell shares of its common stock, ~~including 637,500~~having an aggregate gross sales price of up to $360.0 million. The shares of common stock ~~issued in connection with the exercise in full~~may be sold from time to time through or to one or more of the underwriters' option to purchase additional shares, and received net proceeds of approximately $108.9 million after deducting underwriting discount and commissions and estimated offering expenses payableAgents, as may be determined by the ~~Company.~~Company in its sole discretion, subject to the terms and conditions of the agreement and applicable law.

~~Proceeds from~~The Company's activity under the ~~offering were used to repay~~ATM Program for the ~~outstanding balance on our revolving credit facility totaling $58.0~~three months ended March 31, 2021 is detailed in the table below. As of March 31, 2021, the Company had approximately $119.9 million ~~and for investments during~~remaining that may be issued under the ~~third and fourth quarters of 2017.~~ATM Program.


	Three Months Ended March 31, 2021
Shares issued	435,272
Net proceeds received (in millions)	$	19.9
Average gross sales price per share	$	46.70

Notes to Condensed Consolidated Financial Statements - Continued

~~Universal Shelf S-3 Registration Statement~~

~~On September 13, 2016, the Company filed a registration statement on Form S-3 that allows us to offer debt or equity securities (or a combination thereof) of up to~~ ~~$750.0 million~~ from time to time. The Form S-3 registration statement was declared effective as of September 26, 2016. In July 2017, the Company completed an equity offering and issued approximately 4,887,500 shares of its common stock for gross proceeds of approximately $114.6 million under its Form S-3 registration statement, resulting in approximately $635.4 million remaining to be issued under the Form S-3 registration statement.

Note 8. Net Income Per Common Share

The following table sets forth the computation of basic and diluted net income per common ~~share.~~

share for the three months ended March 31, 2021 and 2020, respectively.

Note 9. Incentive Plan

~~Under~~A summary of the activity under the Company's 2014 Incentive Plan, ~~awards may be made~~as amended, for the three months ended March 31, 2021 and 2020 is included in the ~~form of restricted stock, cash or a combination of both. Compensation~~table below, as well as compensation expense recognized from the amortization of the value of ~~the Company's officer, employee and director~~ shares over the applicable vesting periods during the three months ended September 30, 2017 and 2016 was approximately $0.4 million and $0.2 million, respectively, and during the nine months ended September 30, 2017 and 2016 was approximately $1.1 million and $0.5 million, respectively.periods.


		Three Months Ended March 31,
(Dollars in thousands)		2021		2020
Stock-based awards, beginning of period		1,164,518		909,892
	Stock in lieu of compensation	44,625		50,245
	Stock awards	49,137		53,660
	Total stock granted	93,762		103,905
	Vested shares	(100)		0
Stock-based awards, end of period		1,258,180		1,013,797
Amortization expense		$	1,558	$	1,019

~~A summary of the activity under the 2014 Incentive Plan for the three and nine months ended September 30, 2017 and 2016 is included in the table below.~~

Three Months Ended September 30, Nine Months Ended September 30,
2017 2016 2017 2016
Stock-based awards, beginning of period 434,980
224,895
302,299
85,757
Stock in lieu of compensation 16,452
38,703
80,580
104,110
Stock awards 60,683
38,701
129,236
112,432
Total stock granted 77,135
77,404
209,816
216,542
Stock-based awards, end of period 512,115
302,299
512,115
302,299

Note 10. Other Assets, net

Other assets, consists primarily of notes receivable, accounts receivable, straight-line rent receivables, prepaid assets, deferred financing costs, and above-market intangible assets. Items included in "Other assets, net"net on the Company's Condensed Consolidated Balance Sheets as of ~~September 30, 2017~~March 31, 2021 and December 31, ~~2016~~2020 are detailed in the table below.


	Balance as of
(Dollars in thousands)	March 31, 2021		December 31, 2020
Notes receivable	$	21,630	$	15,010

Accounts and interest receivable	1,522		1,675
Straight-line rent receivable	9,461		8,682

Prepaid assets	642		600
Deferred financing costs, net	1,058		479
Leasing commissions, net	1,093		1,134
Deferred tax assets, net	476		515
Fair value of interest rate swaps	538		0
Above-market lease intangible assets, net	581		617
Sales-type lease receivable	3,021		3,016
Assets held for sale	1,023		0
Operating lease right-of-use assets	821		821
Other	480		501
	$	42,346	$	33,050

The Company's notes receivable mainly included:

•At March 31, 2021 and December 31, 2020, notes receivable included a $14.3 million and $15.0 million, respectively, term loan, secured by all assets and ownership interests in 7 long-term acute care hospitals and 1 inpatient rehabilitation hospital owned by the borrower. The term loan will be repaid in equal monthly installments of $250,000 through the maturity date of December 31, 2025 and bears interest at 9% per annum.

•At March 31, 2021, notes receivable included a $6.0 million term loan and $1.1 million drawn at March 31, 2021 of a $4.0 million revolving credit facility, secured by assets and ownership interests of 6 geriatric behavioral hospitals and affiliated companies all of which are co-borrowers on the loans. The term loan bears interest at 9% per annum, with interest only payments due for the first year and then equal monthly installments of principal payments due beginning March 31, 2022. The term loan facility matures on July 1, 2027. The revolving credit facility bears interest at 9% per annum and matures on December 31, 2025.

The Company identified the borrowers of these notes as variable interest entities ("VIEs"), but management determined that the Company was not the primary beneficiary of the VIEs because we lack either directly or through related parties any material impact in the activities that impact the borrowers' economic performance. We are not obligated to provide support beyond our stated commitment to the borrowers, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding notes receivable.

Balance as of
(Dollars in thousands) September 30, 2017 December 31, 2016
Notes receivable $ 5,704
$ —
Accounts receivable 1,918
2,472
Straight-line rent receivables 1,723
744
Allowance for doubtful accounts (293 ) (154 )
Prepaid assets 355
260
Deferred financing costs, net 716
1,010
Above-market intangible assets, net —
25
Other 653
486
$ 10,776
$ 4,843
The VIEs that we have identified at March 31, 2021 are summarized in the table below.


Classification	Carrying Amount (in millions)		Maximum Exposure to Loss (in millions)
Note receivable	$	14.3	$	14.3
Note receivable	$	1.1	$	1.1
Note receivable	$	6.0	$	6.0

Note 11. Other Liabilities, net

Other liabilities, net on the Company's Condensed Consolidated Balance Sheets as of March 31, 2021 and December 31, 2020 are detailed in the table below.


	Balance as of
(Dollars in thousands)	March 31, 2021		December 31, 2020
Deferred rent	$	3,587	$	2,596
Security deposits	4,208		4,141
Below-market lease intangibles, net	576		613
Fair value of derivatives	8,649		11,846
Lease liability	795		793
Liabilities held for sale	35		0
Other	403		380
	$	18,253	$	20,369

Note ~~11.~~12. Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value.

Cash and cash equivalents and restricted cash - The carrying amount approximates the fair value.

~~Mortgage note receivable~~ ~~- The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes acquired by the Company.~~

Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the ~~Company.~~Company and are classified as level 2 in the hierarchy.

Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates.

Derivative financial instruments - The fair value is estimated using discounted cash flow techniques. These techniques incorporate primarily level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as level 2 in the hierarchy.

Mortgage note payable - The fair value is estimated using cash flow analyses which are based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes assumed by the Company and are classified as level 2 in the hierarchy.

The table below details the fair values and carrying values for our notes receivable, interest rate swaps, and mortgage note ~~and notes receivable~~payable at ~~September 30, 2017~~March 31, 2021 and December 31, ~~2016,~~2020, using ~~Level~~level 2 inputs.


	March 31, 2021				December 31, 2020
(Dollars in thousands)	Carrying Value		Fair Value		Carrying Value		Fair Value

Notes receivable	$	21,630	$	22,063	$	15,010	$	15,010
Interest rate swap asset	$	538	$	538	$	0	$	0
Interest rate swap liability	$	8,649	$	8,649	$	11,846	$	11,846
Mortgage note payable	$	5,151	$	5,391	$	5,180	$	5,432

September 30, 2017 December 31, 2016
(Dollars in thousands) Carrying Value Fair Value Carrying Value Fair Value
Mortgage note receivable $ 10,633
$ 10,633
$ 10,786
$ 10,786
Notes receivable $ 5,704
$ 5,669
$ —
$ —

Note ~~12.~~13. Subsequent Events

On ~~November 2, 2017,~~April 29, 2021, the Company’s Board of Directors declared a quarterly common stock dividend in the amount of ~~$0.395~~$0.43 per share. The dividend is payable on ~~December 1, 2017~~May 28, 2021 to stockholders of record on ~~November 17, 2017.~~May 14, 2021.

~~Property~~Real Estate Acquisitions

~~During the fourth quarter of 2017, through November 7, 2017,~~Subsequent to March 31, 2021, the Company acquired ~~three real estate properties totaling~~1 property for a purchase price of approximately ~~105,500 square feet for an aggregate purchase price~~$4.2 million and cash consideration of approximately ~~$25.9~~$3.5 million. ~~Upon acquisition, the properties were 100%~~The property was approximately 90.9% leased with lease expirations ~~ranging from 2025~~ through ~~2032. These acquisitions were~~2028. This acquisition was funded with ~~net proceeds remaining from the Company's July 2017 equity offering and from the Company's Revolving Credit Facility.~~cash on hand.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Disclosure Regarding Forward-Looking Statements

This report and other materials that Community Healthcare Trust Incorporated (the "Company") has filed or may file with the Securities and Exchange Commission, as well as information included in oral statements or other written statements made, or to be made, by management of the Company, contain, or will contain,~~contains~~ statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identifiable by use of forward-looking terminology such as “believes”, “expects”, “may”, “should”, “seeks”, “approximately”, “intends”, “plans”, “estimates”, “anticipates” or other similar words or expressions, including the negative thereof. Forward-looking statements are based on certain assumptions and can include future expectations, future plans and strategies, financial and operating projections or other forward-looking information. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. Thus, the Company’s actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, the Company’s ability to refinance existing indebtedness at or prior to maturity on favorable terms, or at all, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract, effects on global and national markets as well as businesses resulting from the COVID-19 pandemic, and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2016, the Company's Quarterly Reports on Form 10-Q for the three months ended March 31, 2017 and June 30, 2017,~~2020, and the Company’s other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this report and the Company undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.

The purpose of this Management's Discussion and Analysis ("MD&A") is to provide an understanding of the Company's consolidated financial condition, results of operations and cash. MD&A is provided as a supplement to, and should be read in conjunction with, the Company's Condensed Consolidated Financial Statements and accompanying notes.

References such as "we," "us," "our," and "the Company" mean Community Healthcare Trust Incorporated, a Maryland corporation, and its consolidated ~~subsidiaries, including Community Healthcare OP, LP, a Delaware limited partnership of which we are the sole general partner (the "OP").~~subsidiaries.

We were organized in the State of Maryland on March 28, 2014. We are a self-administered, self-managed healthcare real estate investment trust, or REIT, that acquires and owns properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in our target submarkets. The Company conducts its business through an UPREIT structure in which its properties are owned by the OP, either directly or through subsidiaries. The Company is the sole general partner, owning 100% of the OP units.providers.

Trends and Matters Impacting Operating Results

Management ~~will monitor~~monitors factors and trends that it believes are important to the Company and the REIT industry in order to gauge their potential impact on the operations of the Company. Certain of the factors and trends that management believes may impact the operations of the Company are discussed below.

~~Property~~Real estate acquisitions

During the ~~third~~first quarter of ~~2017,~~2021, the Company acquired ~~two~~six real estate properties totaling approximately ~~147,000~~159,000 square feet for an aggregate purchase price of approximately $59.8 million and cash consideration of approximately ~~$28.3~~$60.0 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ~~ranging from 2022~~ through ~~2032. In addition, we funded~~2036. Concurrent with the acquisitions, the Company entered into a ~~$5.0~~$6.0 million ~~mezzanine~~term loan and a revolver loan up to $4.0 million with the tenant on two of ~~one of~~these properties. These acquisitions were funded with cash on hand, proceeds from the ~~properties.~~

~~During~~Company's ATM Program, and proceeds from the second quarter of 2017, the Company acquired 10 real estate properties totaling approximately 203,000 square feet for an aggregate purchase price of approximately $36.2 million, including cash consideration of approximately $35.9 million. Upon acquisition, the properties were 100% leased in the aggregate with lease expirations ranging from 2019 through 2032.

During the first quarter of 2017, the Company acquired ten real estate properties totaling approximately 145,000 square feet for an aggregate purchase price of approximately $28.5 million, including cash consideration of approximately $28.4 million. Upon acquisition, the properties were approximately 95.2% leased in the aggregate with lease expirations ranging from 2018 through 2032. During the first quarter of 2017, the Company also acquired a property, adjacent to its corporate office, for a cash purchase price of approximately $0.9 million. The property is currently leased to a tenant but the Company intends to use the property for future expansion of its corporate office.

Company's Revolving Credit Facility. See Note 4 to the Condensed Consolidated Financial Statements for more details on these acquisitions.

Subsequent ~~acquisitions~~

~~During the fourth quarter of 2017, through November 7, 2017,~~to March 31, 2021, the Company acquired ~~three real estate properties totaling~~one property for a purchase price of approximately ~~105,500 square feet for an aggregate purchase price~~$4.2 million and cash consideration of approximately ~~$25.9~~$3.5 million. ~~Upon acquisition, the properties were 100%~~The property was approximately 90.9% leased with lease expirations ~~ranging from 2025~~ through ~~2032. These acquisitions were~~2028. This acquisition was funded with ~~net proceeds remaining from the Company's July 2017 equity offering and from the Company's Revolving Credit Facility.~~cash on hand.

Acquisition Pipeline

The Company has ~~four~~two properties under definitive purchase agreements for an aggregate expected purchase price of approximately ~~$20.3 million. The Company's~~$8.4 million and expected return on these investments range from approximately 9% to 10.5%. The Company anticipates these properties will close during the fourth quarter. However, the Company is currently performing due diligence procedures customary for these types of transactions and cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

~~The Company also has three properties under definitive purchase agreements, to be acquired after completion and occupancy, for an~~ aggregate ~~expected purchase price~~returns of approximately ~~$40.4 million.~~9.3%. The Company expects to close on ~~one of~~ these properties ~~sometime in the first half of 2018 and expects to close on the remaining two properties sometime in~~during the second ~~half~~or third quarter of ~~2018. The Company's expected aggregate return on these investments ranges up to approximately 11%. However,~~2021; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.

The Company ~~anticipates funding~~expects to fund these ~~investments~~acquisitions with cash ~~from operations, through~~on hand, proceeds from ~~its Credit Facility or from net~~the Company's ATM Program, and proceeds from ~~additional debt or equity offerings.~~the Company's Revolving Credit Facility.

Pursuant to the exercise of a purchase option by a tenant, the Company entered into a sales contract to dispose of a medical office building in Haleyville, Alabama during the first quarter of 2021. The Company expects to close on this transaction in the second quarter of 2021 and expects to recognize a gain on the sale. Assets held for sale totaling approximately $1.0 million are included in Other assets, net and Liabilities held for sale totaling $35,000 are included in Other liabilities, net on the Condensed Consolidated Balance Sheet as of March 31, 2021.

Leased square footage

As of ~~September 30, 2017,~~March 31, 2021, our real estate portfolio was approximately ~~92.1%~~89.1% leased. During the ~~third quarter~~first three months of ~~2017,~~2021, we had expiring or terminated leases related to approximately ~~40,000~~7,000 square feet, and we leased or renewed leases relating to approximately ~~20,000~~21,000 square feet.

~~Equity Offering~~COVID-19 pandemic

During 2020, the world was, and continues to be, impacted by the novel coronavirus (COVID-19) pandemic. COVID-19 and measures to prevent its spread impacted many healthcare providers, including some of our tenants. During 2020, some of them were not seeing patients, others saw a reduced number of elective procedures and/or patient visits, while others experienced limited impact, or even saw improved cash flows from either increases in census or government funding.

~~On July 26, 2017,~~During 2020, as a result of the pandemic, the Company ~~completed a public offering~~entered into deferral agreements with 18 tenants, with deferrals representing less than one percent of ~~4,887,500 shares of its common stock, including 637,500 shares of common stock issued~~our annualized rent in ~~connection with~~ the ~~exercise in full of~~aggregate. Amounts due under the ~~underwriters' option~~deferral agreements were generally repaid during 2020, however, at March 31, 2021, there was approximately $51,000 remaining to ~~purchase additional shares,~~be billed and ~~received net proceeds of approximately $108.9 million after deducting underwriting discount and commissions and estimated offering expenses payable by the Company.~~

~~Proceeds from the offering were used to repay the outstanding balance on our revolving credit facility totaling $58.0 million and for investments~~paid during the ~~third and fourth quarters~~remainder of ~~2017.~~2021.

~~Off-Balance Sheet Arrangements~~

~~We have no off-balance sheet arrangements that are reasonably likely to have a material effect on the Company's consolidated financial condition, results of operations or liquidity.~~

We believe inflation will have a minimal impact on the operating performance of our properties. Many of our lease agreements contain provisions designed to mitigate the adverse impact of inflation. These provisions include clauses that enable us to receive payment of increased rent pursuant to escalation clauses which generally increase rental rates during the terms of the leases. These escalation clauses often provide for fixed rent increases or indexed escalations (based upon the Consumer Price Index or other measures). However, some of these contractual rent increases may be less than the actual rate of inflation. Generally, our lease agreements require the tenant to pay property operating expenses, including maintenance costs, real estate taxes and insurance. This requirement reduces our exposure to increases in these costs and property operating expenses resulting from inflation.

We do not expect our business to be subject to material seasonal fluctuations.

New Accounting Pronouncements

See Note 1 to the Company’s Condensed Consolidated Financial Statements accompanying this report for information on new accounting standards recently adopted and not yet adopted.

Results of Operations

The Company's results of operations for the three months ended ~~September 30, 2017~~March 31, 2021 compared to the same period in ~~2016~~2020 have most significantly been impacted by its real estate acquisitions. As of ~~September 30, 2017~~March 31, 2021 and ~~2016,~~2020, the Company had investments in real estate properties ~~including a mortgage note,~~ totaling approximately ~~$358.0~~$801.0 million (including a portion of one property accounted for as a financing lease with a gross amount totaling approximately $3.0 million and ~~$217.6~~one property classified as held for sale with a gross amount totaling approximately $1.1 million) and $641.9 million, respectively.

Three Months Ended ~~September 30, 2017~~March 31, 2021 Compared to Three Months Ended ~~September 30, 2016~~

The table below shows our results of operations for the three months ended ~~September 30, 2017~~March 31, 2021 compared to the same period in ~~2016~~2020 and the effect of changes in those results from period to period on our net income.


	Three Months Ended March 31,				Increase (decrease) to Net income
(dollars in thousands)	2021		2020		$		%
REVENUES
Rental income	$	20,780	$	17,428	$	3,352	19.2	%

Other operating interest	615		508		107		21.1	%
	21,395		17,936		3,459		19.3	%
EXPENSES
Property operating	3,729		3,343		(386)		(11.5)	%
General and administrative	2,859		2,192		(667)		(30.4)	%
Depreciation and amortization	7,225		6,059		(1,166)		(19.2)	%
	13,813		11,594		(2,219)		(19.1)	%

INCOME FROM OPERATIONS	7,582		6,342		1,240		19.6	%

Interest expense	(2,229)		(2,249)		20		0.9	%
Deferred income tax expense	(39)		—		(39)		n/m
Other income	1		7		(6)		(85.7)	%

NET INCOME	$	5,315	$	4,100	$	1,215	29.6	%

n/m - not meaningful

Three Months Ended September 30, Increase (Decrease) to Net Income
(dollars in thousands) 2017 2016 $
REVENUES
Rental income $ 8,012
$ 4,985
$ 3,027
Tenant reimbursements 1,158
1,188
(30 )
Mortgage interest 255
270
(15 )
Other operating 19
—
19
9,444
6,443
3,001
EXPENSES
Property operating 2,225
963
(1,262 )
General and administrative 1,069
671
(398 )
Depreciation and amortization 4,544
3,496
(1,048 )
Bad debts —
73
73
7,838
5,203
(2,635 )
OTHER INCOME (EXPENSE)
Interest expense (1,091 ) (185 ) (906 )
Interest and other income, net 64
9
55
(1,027 ) (176 ) (851 )
NET INCOME $ 579
$ 1,064
$ (485 )


Maryland						46-5212033
(State or Other Jurisdiction of Incorporation or Organization)						~~46-5212033~~ (I.R.S. Employer Identification No.)



	Page
PART I.—FINANCIAL INFORMATION
Item 1.		Financial Statements (Unaudited)	3
		Condensed Consolidated Balance Sheets	3
		Condensed Consolidated Statements of Income	4
		Condensed Consolidated Statements of Comprehensive Income (Loss)	5
		Condensed Consolidated ~~Statement~~Statements of Stockholders' Equity	6
		Condensed Consolidated Statements of Cash Flows	7
		Notes to Condensed Consolidated Financial Statements	8
Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations	2521
Item 3.		Quantitative and Qualitative Disclosures about Market Risk	3730
Item 4.		Controls and Procedures	3730

PART II.—OTHER INFORMATION			3731
Item 1.		Legal Proceedings	3731
Item 1A.		Risk Factors	3731
Item 2.		Unregistered Sales of Equity Securities and Use of Proceeds	3831
Item 3.		Defaults Upon Senior Securities	3831
Item 4.		Mine Safety Disclosures	3831
Item 5.		Other Information	3831
Item 6.		Exhibits	3831

SIGNATURES			4033


	Nine Months Ended September 30,							Three Months Ended March 31,
	2017			2016				2021		2020
OPERATING ACTIVITIES							OPERATING ACTIVITIES
Net income	$	1,958		$	1,688		Net income	$	5,315	$	4,100
Adjustments to reconcile net income to net cash provided by operating activities:							Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	13,053			9,749			Depreciation and amortization	7,225		6,059
Other amortization							Other amortization	229		127
Stock-based compensation	1,050			453			Stock-based compensation	1,550		1,013
Straight-line rent receivable	(980		)	(405		)	Straight-line rent receivable	(838)		(878)
Straight-line rent liability	27			—
Provision for bad debts, net of recoveries	67			103
Reduction in contingent purchase price	(5		)	(974		)

Deferred income tax expense							Deferred income tax expense	39		0
Changes in operating assets and liabilities:							Changes in operating assets and liabilities:
Other assets	(636		)	(1,284		)	Other assets	(291)		(235)
Accounts payable and accrued liabilities	(404		)	1,732			Accounts payable and accrued liabilities	(820)		396
Other liabilities	1,234			(262		)	Other liabilities	1,084		(329)
Net cash provided by operating activities	15,364			10,800			Net cash provided by operating activities	13,493		10,253

INVESTING ACTIVITIES							INVESTING ACTIVITIES
Acquisitions of real estate	(93,442		)	(58,249		)	Acquisitions of real estate	(60,007)		(36,384)
Funding of notes receivable	(5,000		)	(12,406		)

Acquisition and funding of notes receivable							Acquisition and funding of notes receivable	(7,110)		(1,750)

Proceeds from the repayment of notes receivable	296			—			Proceeds from the repayment of notes receivable	890		3,300
Capital expenditures on existing real estate properties	(545		)	(1,123		)	Capital expenditures on existing real estate properties	(1,045)		(673)
Net cash used in investing activities	(98,691		)	(71,778		)	Net cash used in investing activities	(67,272)		(35,507)

FINANCING ACTIVITIES							FINANCING ACTIVITIES
Net repayments on revolving credit facility	(51,000		)	(12,000		)
Net (repayments) borrowings on revolving credit facility							Net (repayments) borrowings on revolving credit facility	(26,000)		9,000
Term loan borrowings	60,000			—			Term loan borrowings	125,000		0
Term loan repayments							Term loan repayments	(50,000)		0
Mortgage note repayments							Mortgage note repayments	(29)		(27)
Dividends paid	(17,288		)	(12,782		)	Dividends paid	(10,275)		(9,033)
Net proceeds from issuance of common stock	109,168			86,805
Proceeds from issuance of common stock							Proceeds from issuance of common stock	19,919		26,928
Equity issuance costs	(465		)	(680		)	Equity issuance costs	(76)		(29)
Debt issuance costs	(784		)	(641		)	Debt issuance costs	(1,649)		0
Settlement of contingent purchase price	(393		)	—

Net cash provided by financing activities	99,238			60,702			Net cash provided by financing activities	56,890		26,839
Increase (decrease) in cash and cash equivalents	15,911			(276		)
Cash and cash equivalents, beginning of period	1,568			2,018
Cash and cash equivalents, end of period	$	17,479		$	1,742
Increase in cash and cash equivalents and restricted cash							Increase in cash and cash equivalents and restricted cash	3,111		1,585
Cash and cash equivalents and restricted cash, beginning of period							Cash and cash equivalents and restricted cash, beginning of period	2,892		2,023
Cash and cash equivalents and restricted cash, end of period							Cash and cash equivalents and restricted cash, end of period	$	6,003	$	3,608

Supplemental Cash Flow Information:							Supplemental Cash Flow Information:
Interest paid	$	2,390		$	504		Interest paid	$	2,105	$	1,876
Invoices accrued for construction, tenant improvement and other capitalized costs	$	3		$	145		Invoices accrued for construction, tenant improvement and other capitalized costs	$	1,591	$	1,165
Reclassification between accounts and notes receivable	$	615		$	—

Reclassification of registration statement costs incurred in prior year to equity issuance costs	$	148		$	—		Reclassification of registration statement costs incurred in prior year to equity issuance costs	$	81	$	32
Conversion of mortgage note upon acquisition of real estate property	$	—		$	12,500
Decrease in fair value of cash flow hedges	$	(672	)	$	—
Leasing commission accrued							Leasing commission accrued	$	0	$	125
Increase (decrease) in fair value of cash flow hedges							Increase (decrease) in fair value of cash flow hedges	$	2,803	$	(8,875)
Income taxes paid							Income taxes paid	$	25	$	2


2021 (nine months ending December 31)	$	54,162
2022	69,078
2023	64,608
2024	61,072
2025	56,774
2026 and thereafter	365,330
	$	671,024


														Three Months Ended March 31,
	Three Months Ended September 30, 2017						Nine Months Ended September 30, 2017
(Dollars in thousands, except per share data)	2017			2016			2017			2016
(In thousands, except per share data)													(In thousands, except per share data)	2021		2020
Net income	$	579		$	1,064		$	1,958		$	1,688		Net income	$	5,315	$	4,100
Participating securities' share in earnings	(200		)	—			(526		)	—			Participating securities' share in earnings	(538)		(424)
Net income, less participating securities' share in earnings	$	379		$	1,064		$	1,432		$	1,688		Net income, less participating securities' share in earnings	$	4,777	$	3,676

Weighted average Common Shares outstanding													Weighted average Common Shares outstanding
Weighted average Common Shares outstanding	16,719,150			12,948,097			14,319,231			10,972,011			Weighted average Common Shares outstanding	24,053		21,733
Unvested restricted stock	(477,164		)	(261,914		)	(434,755		)	(219,678		)
Unvested restricted shares													Unvested restricted shares	(1,244)		(998)
Weighted average Common Shares outstanding–Basic	16,241,986			12,686,183			13,884,476			10,752,333			Weighted average Common Shares outstanding–Basic	22,809		20,735
Weighted average Common Shares outstanding–Basic	16,241,986			12,686,183			13,884,476			10,752,333

Dilutive potential common shares	—			64,784			—			49,762			Dilutive potential common shares	0		0
Weighted average Common Shares outstanding –Diluted	16,241,986			12,750,967			13,884,476			10,802,095			Weighted average Common Shares outstanding –Diluted	22,809		20,735

Basic Net Income per Common Share	$	0.02		$	0.08		$	0.10		$	0.16		Basic Net Income per Common Share	$	0.21	$	0.18

Diluted Net Income per Common Share	$	0.02		$	0.08		$	0.10		$	0.16		Diluted Net Income per Common Share	$	0.21	$	0.18


	(Unaudited)
	March 31, 2021		December 31, 2020
ASSETS
Real estate properties
Land and land improvements	$	91,428	$	83,714
Buildings, improvements, and lease intangibles	705,224		651,398
Personal property	218		247
Total real estate properties	796,870		735,359
Less accumulated depreciation	(109,908)		(102,899)
Total real estate properties, net	686,962		632,460
Cash and cash equivalents	5,605		2,483
Restricted cash	398		409

Other assets, net	42,346		33,050
Total assets	$	735,311	$	668,402

LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Debt, net	$	260,446	$	212,374
Accounts payable and accrued liabilities	6,526		5,743
Other liabilities, net	18,253		20,369
Total liabilities	285,225		238,486

Commitments and contingencies			0

0Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; NaN issued and outstanding	0		0
Common stock, $0.01 par value; 450,000,000 shares authorized; 24,417,124 and 23,888,090 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	244		239
Additional paid-in capital	571,781		550,391
Cumulative net income	41,946		36,631
Accumulated other comprehensive loss	(8,111)		(11,846)
Cumulative dividends	(155,774)		(145,499)
Total stockholders’ equity	450,086		429,916
Total liabilities and stockholders' equity	$	735,311	$	668,402



	(Unaudited)
	September 30, 2017			December 31, 2016
ASSETS
Real estate properties
Land and land improvements	$	39,810		$	29,884
Buildings, improvements, and lease intangibles	307,492			222,755
Personal property	112			97
Total real estate properties	347,414			252,736
Less accumulated depreciation	(31,153		)	(18,404		)
Total real estate properties, net	316,261			234,332
Cash and cash equivalents	17,479			1,568
Mortgage note receivable, net	10,633			10,786
Other assets, net	10,776			4,843
Total assets	$	355,149		$	251,529

LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Debt, net	$	59,284		$	51,000
Accounts payable and accrued liabilities	3,226			3,541
Other liabilities	4,743			2,981
Total liabilities	67,253			57,522

Commitments and contingencies

Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding	—			—
Common stock, $0.01 par value; 450,000,000 shares authorized; 18,085,798 and 12,988,482 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	181			130
Additional paid-in capital	323,877			214,323
Cumulative net income	3,223			1,265
Accumulated other comprehensive loss	(386		)	—
Cumulative dividends	(38,999		)	(21,711		)
Total stockholders’ equity	287,896			194,007
Total liabilities and stockholders' equity	$	355,149		$	251,529



	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
REVENUES
Rental income	$	8,012		$	4,985		$	21,968		$	13,188
Tenant reimbursements	1,158			1,188			3,620			3,250
Mortgage interest	255			270			774			1,367
Other operating	19			—			19			—
	9,444			6,443			26,381			17,805

EXPENSES
Property operating	2,225			963			6,103			3,240
General and administrative	1,069			671			2,674			2,372
Depreciation and amortization	4,544			3,496			12,749			9,643
Bad debts	—			73			67			103
	7,838			5,203			21,593			15,358
OTHER INCOME (EXPENSE)
Interest expense	(1,091		)	(185		)	(2,897		)	(787		)
Interest and other income, net	64			9			67			28
	(1,027		)	(176		)	(2,830		)	(759		)
NET INCOME	$	579		$	1,064		$	1,958		$	1,688

NET INCOME PER COMMON SHARE:
Net income per common share – Basic	$	0.02		$	0.08		$	0.10		$	0.16
Net income per common share – Diluted	$	0.02		$	0.08		$	0.10		$	0.16
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC	16,241,986			12,686,183			13,884,476			10,752,333
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED	16,241,986			12,750,967			13,884,476			10,802,095
DIVIDENDS DECLARED, PER COMMON SHARE, DURING THE PERIOD	$	0.3925		$	0.3825		$	1.1700		$	1.1400



(Dollars in thousands)	Number of Facilities	Land and Land Improvements		Buildings, Improvements, and Lease Intangibles		Personal Property		Total		Accumulated Depreciation
Medical office buildings:
Florida	4	$	4,138	$	23,777	$	—	$	27,915	$	2,168
Ohio	5	3,167		23,518		—		26,685		2,912
Texas	3	3,096		12,315		—		15,411		2,950
Kansas	2	1,427		10,497		—		11,924		2,317
Iowa	1	2,241		8,979		—		11,220		885
Illinois	2	1,134		11,791		—		12,925		1,374
Virginia	1	369		4,649		—		5,018		156
Other states	13	3,273		22,695		—		25,968		1,970
	31	18,845		118,221		—		137,066		14,732
Physician clinics:
Kansas	3	1,638		10,899		—		12,537		1,780
Florida	3	—		5,950		—		5,950		462
Illinois	1	1,891		3,134		—		5,025		31
Other states	9	3,195		18,461		—		21,656		2,719
	16	6,724		38,444		—		45,168		4,992
Surgical centers and hospitals:
Louisiana	1	1,683		21,353		—		23,036		444
Indiana	1	523		14,405		—		14,928		188
Michigan	2	628		8,272		—		8,900		1,713
Illinois	1	2,183		5,410		—		7,593		634
Florida	1	271		7,004		—		7,275		118
Arizona	2	576		5,389		—		5,965		874
Other states	5	1,555		11,001		—		12,556		2,675
	13	7,419		72,834		—		80,253		6,646
Specialty centers:
Alabama	3	415		4,417		—		4,832		1,170
Nevada	1	276		4,402		—		4,678		183
Kentucky	1	193		3,432		—		3,625		732
Other states	10	1,716		15,227		—		16,943		1,786
	15	2,600		27,478		—		30,078		3,871
Behavioral facilities:
West Virginia	1	2,138		22,897		—		25,035		7
Illinois	1	1,300		18,803		—		20,103		627
Ohio	1	514		4,153		—		4,667		52
Indiana	1	270		2,651		—		2,921		127
	4	4,222		48,504		—		52,726		813
Corporate property	—	—		2,011		112		2,123		99
Total owned properties	79	$	39,810	$	307,492	$	112	$	347,414	$	31,153
Mortgage note receivable, net	1	—		—		—		10,633		—
Total real estate investments	80	$	39,810	$	307,492	$	112	$	358,047	$	31,153



2017	$	8,292
2018	30,409
2019	27,202
2020	24,497
2021	21,541
2022 and thereafter	134,018
	$	245,959



	Estimated Fair Value			Estimated Useful Life
	(In thousands)			(In years)
Land and land improvements	$	9,715		5 - 7.5
Building and building improvements	74,891			20 - 40
Intangibles:
In place lease intangibles	9,527			1.4 - 8.9
Total intangibles	9,527
Accounts receivable and other assets assumed	32
Accounts payable, accrued liabilities and other liabilities assumed ⁽¹⁾	(416		)
Prorated rent, interest and operating expense reimbursement amounts collected	(307		)
Total cash consideration	$	93,442

⁽¹⁾ Includes security deposits received.



	Balance as of
(Dollars in thousands)	September 30, 2017		December 31, 2016		Maturity Dates

Revolving Credit Facility	$	—	$	51,000	8/19
5-Year Term Loan, net	29,648		—		3/22
7-Year Term Loan, net	29,636		—		3/24
	$	59,284	$	51,000


	Three Months Ended March 31, 2021	Year Ended December 31, 2020
Balance, beginning of period	23,888,090	21,410,578
Issuance of common stock	435,272	2,206,976
Restricted stock-based awards	93,762	270,536
Balance, end of period	24,417,124	23,888,090



	Nine Months Ended September 30, 2017	Year Ended December 31, 2016
Balance, beginning of period	12,988,482	7,596,940
Issuance of common stock	4,887,500	5,175,000
Restricted stock-based awards	209,816	216,542
Balance, end of period	18,085,798	12,988,482



	Three Months Ended September 30,						Increase (Decrease) to Net Income
(dollars in thousands)	2017			2016			$
REVENUES
Rental income	$	8,012		$	4,985		$	3,027
Tenant reimbursements	1,158			1,188			(30		)
Mortgage interest	255			270			(15		)
Other operating	19			—			19
	9,444			6,443			3,001
EXPENSES
Property operating	2,225			963			(1,262		)
General and administrative	1,069			671			(398		)
Depreciation and amortization	4,544			3,496			(1,048		)
Bad debts	—			73			73
	7,838			5,203			(2,635		)
OTHER INCOME (EXPENSE)
Interest expense	(1,091		)	(185		)	(906		)
Interest and other income, net	64			9			55
	(1,027		)	(176		)	(851		)
NET INCOME	$	579		$	1,064		$	(485	)



~~Maryland~~


	Three Months Ended March 31,
(In thousands, excepts per share amounts)	2021		2020
Net income	$	5,315	$	4,100
Real estate depreciation and amortization	7,276		6,109


FFO	$	12,591	$	10,209
Straight-line rent	(838)		(878)
Stock-based compensation	1,558		1,019
AFFO	$	13,311	$	10,350

FFO per diluted common share	$	0.54	$	0.48

AFFO per diluted common share	$	0.57	$	0.49
Weighted average common shares outstanding - diluted (1)	23,500		21,310



	Three Months Ended September 30,				Nine Months Ended September 30,
(Dollars in thousands, excepts per share amounts)	2017		2016		2017		2016
Net income	$	579	$	1,064	1,958		$	1,688
Real estate depreciation and amortization	4,539		3,493		12,736		9,637
Total adjustments	4,539		3,493		12,736		9,637
Funds from Operations	$	5,118	$	4,557	$	14,694	$	11,325
Funds from Operations per Common Share-Basic	$	0.32	$	0.36	$	1.06	$	1.05
Funds from Operations per Common Share-Diluted	$	0.31	$	0.36	$	1.05	$	1.05
Weighted Average Common Shares Outstanding-Basic	16,241,986		12,686,183		13,884,476		10,752,333
Weighted Average Common Shares Outstanding-Diluted	16,401,718		12,750,967		14,035,185		10,802,095



Exhibit ~~Number~~ No.						Description
3.1						Corporate Charter of Community Healthcare Trust Incorporated, as amended (1)
3.2						Amended and Restated Bylaws of Community Healthcare Trust Incorporated ~~as amended~~ (2)
10.1						Fifth Amendment ~~No. 2~~ to ~~the 2014 Incentive Plan of~~Employment Agreement between Community Healthcare Trust Incorporated and Timothy G. Wallace (3)
10.2						Second Amendment ~~No. 3~~ to ~~the 2014 Incentive Plan of~~Employment Agreement between Community Healthcare Trust Incorporated and David H. Dupuy (4)
10.3						~~Underwriting~~Second Amendment to Amended and Restated Employment Agreement between Community Healthcare Trust Incorporated and Leigh Ann Stach (5)
10.4						Second Amended and Restated Executive Officer Incentive Program, adopted as of February 11, 2021 (6)
10.5						Third Amended and Restated Credit Agreement, dated ~~July 20, 2017,~~as of March 19, 2021, by and among Community Healthcare Trust Incorporated, ~~Community Healthcare OP, LP, Sandler O’Neill & Partners, L.P., Evercore Group L.L.C.~~as borrower, the several banks and ~~SunTrust Robinson Humphrey, Inc.,~~financial institutions party thereto as ~~representatives of the underwriters named in Schedule A of the Underwriting Agreement (5)~~lenders, and Truist Bank, as administrative agent (7)
31.1 *						Certification of the Chief Executive Officer of Community Healthcare Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Rule 302 of the Sarbanes-Oxley Act of 2002 of the Chief Executive Officer of Community Healthcare Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Rule 302 of the Sarbanes-Oxley Act of 2002
31.2 *						Certification of the Chief Financial Officer of Community Healthcare Trust Incorporated pursuant to Rule Certification of the Chief Financial Officer of Community Healthcare Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Rule 302 of the Sarbanes-Oxley Act of 2002 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Rule 302 of the Sarbanes-Oxley Act of 2002
32.1 **						Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS						Inline XBRL Instance Document
101.SCH						Inline XBRL Taxonomy Extension Schema Document
101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB						Inline XBRL Taxonomy Extension Labels Linkbase Document
101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document
101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document
104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)


~~(1)~~	~~Filed as Exhibit 3.1 to Amendment No. 2 to the Registration Statement on Form S-11 of the Company filed with the Securities and Exchange Commission on May 6, 2015 (Registration No. 333-203210)and incorporated herein by reference.~~


~~(2)~~	~~Filed as Exhibit 3.2 to the Registration Statement on Form S-11 of the Company filed with the Securities and Exchange Commission on April 2, 2015 (Registration No. 333-203210)and incorporated herein by reference.~~


~~(3)~~	~~Filed as Exhibit 10.1 to the Form 8-K of the Company filed with the Securities and Exchange Commission on July 17, 2017.~~


~~(4)~~	~~Filed as Exhibit 10.2 to the Form 8-K of the Company filed with the Securities and Exchange Commission on July 17, 2017.~~


~~(5)~~	~~Filed as Exhibit 1.1 to the Form 8-K of the Company filed with the Securities and Exchange Commission on July 26, 2017.~~


			COMMUNITY HEALTHCARE TRUST INCORPORATED

			~~COMMUNITY HEALTHCARE TRUST INCORPORATED~~
By:
	~~By:~~	/s/ Timothy G. Wallace
				Timothy G. Wallace
				Chief Executive Officer and President

			By:	/s/ ~~W. Page Barnes~~David H. Dupuy
				~~W. Page Barnes~~David H. Dupuy
				Executive Vice President and Chief Financial Officer